Overview

  • Product name
    Anti-COCH antibody - C-terminal
    See all COCH primary antibodies
  • Description
    Rabbit polyclonal to COCH - C-terminal
  • Host species
    Rabbit
  • Tested applications
    Suitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide within Human COCH aa 499-528 (C terminal) conjugated to Keyhole Limpet Haemocyanin (KLH). The exact sequence is proprietary.
    Database link: O43405

  • Positive control
    • 293 cell line lysate, COCH- transiently transfected 293 cell lysate

Properties

Applications

Our Abpromise guarantee covers the use of ab170266 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/500. Predicted molecular weight: 59 kDa.

Target

  • Function
    Plays a role in the control of cell shape and motility in the trabecular meshwork.
  • Tissue specificity
    Expressed in inner ear structures; the cochlea and the vestibule.
  • Involvement in disease
    Defects in COCH are the cause of deafness autosomal dominant type 9 (DFNA9) [MIM:601369]. DFNA9 is a form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA9 is characterized by onset in the fourth or fifth decade of life and initially involves the high frequencies. Deafness is progressive and usually complete by the sixth decade. In addition to cochlear involvement, DFNA9 patients also exhibit a spectrum of vestibular dysfunctions. Penetrance of the vestibular symptoms is often incomplete, and some patients are minimally affected, whereas others suffer from severe balance disturbances and episodes of vertigo. Affected individuals have mucopolysaccharide depositions in the channels of the cochlear and vestibular nerves. These depositions apparently cause strangulation and degeneration of dendritic fibers.
  • Sequence similarities
    Contains 1 LCCL domain.
    Contains 2 VWFA domains.
  • Post-translational
    modifications
    N-glycosylated.
    A 50 kDa form is created by proteolytic cleavage.
  • Cellular localization
    Secreted > extracellular space > extracellular matrix.
  • Information by UniProt
  • Database links
  • Alternative names
    • Coagulation factor C homolog, cochlin (Limulus polyphemus) antibody
    • COCH antibody
    • COCH-5B2 antibody
    • COCH_HUMAN antibody
    • COCH5B2 antibody
    • Cochlin antibody
    • DFNA9 antibody
    see all

Images

  • All lanes : Anti-COCH antibody - C-terminal (ab170266) at 1/100 dilution

    Lane 1 : Non-transfected 293 cell lysate
    Lane 2 : COCH-transiently transfected 293 cell lysate

    Lysates/proteins at 2 µg per lane.

    Predicted band size: 59 kDa

  • Anti-COCH antibody - C-terminal (ab170266) at 1/100 dilution + 293 cell line lysate at 35 µg

    Predicted band size: 59 kDa

References

ab170266 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab170266.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up